Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Category</td><td class="align_center">MBC (<i>n</i> = 33<sup>a</sup>)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Local recurrence</td><td class="align_center">0.00 (0.00%)</td></tr><tr><td class="align_left">Distant metastasis</td><td class="align_center">11.00 (33.33%)</td></tr><tr><td class="align_left">Death</td><td class="align_center">8.00<sup>b</sup> (24.24%)</td></tr><tr><td class="align_left">Median follow-up time (month, IQR)</td><td class="align_center">25.00 (15.00∼56.00)</td></tr><tr><td class="align_left">5-year survival rate</td><td class="align_center">57.66%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>a. A total of 37 MBC patients were followed up, 33 of them were able to collect complete information, and 1 of them was in stage IV at the time of diagnosis. b. All 8 patients died of MBC. MBC: metaplastic breast carcinoma; IQR: interquartile range.<br/></div></td></tr></table>

The Breast Journal

tab4

Table 4

Table 4: Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma 

Table 4 | Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma 